PMC-001

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamePMC-001
Drug Alias NameIgG bispecific mAb (PharmAbcine)VEGFR-2/TIE 2 (PharmAbcine)DIG-KTSSS-25PMC-001 +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsTEK receptor tyrosine kinase antagonistsAnticancer protein kinase inhibitors
TargetsVascular endothelial growth factor receptor 2TEK receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPending
Originator CompaniesPharmAbcine Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmAbcine Inc
Inactive Companies3sbio IncTriphase Accelerator Corp
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A